| Clinical characteristics | n | |
| Age (years) | ≥50 | 25 |
| <50 | 26 | |
| Menopausal | No | 22 |
| Yes | 29 | |
| Paracentesis type | Invasive duct carcinoma | 38 |
| Invasive small-leaf cancer | 3 | |
| Myeloid cancer | 1 | |
| TNM periodization | IIb | 14 |
| IIIa | 32 | |
| IIIb | 4 | |
| IIIc | 1 | |
| ER | − | 16 |
| + | 7 | |
| ++ | 8 | |
| +++ | 20 | |
| PR | − | 20 |
| + | 15 | |
| ++ | 19 | |
| +++ | 7 | |
| HER-2 | 0 | 23 |
| + | 8 | |
| ++ | 10 | |
| +++ | 10 | |
| Chemotherapy programme | EC | 41 |
| EC-T | 4 | |
| TEC | 4 | |
| NP | 2 | |
| Preoperative chemotherapy | ≤3 | 23 |
| >3 | 28 | |
| Molecular typing of breast cancer | Luminal subtype | 34 |
| Her-2 over-expression subtype | 9 | |
| Triple Negative subtype | 8 | |